These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 7690921
1. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG. Levavi H, Neri A, Bar J, Regev D, Nordenberg J, Ovadia J. Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921 [Abstract] [Full Text] [Related]
2. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases. Zhang WY, Yen GL. Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674 [Abstract] [Full Text] [Related]
7. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles. Berkowitz R, Ozturk M, Goldstein D, Bernstein M, Hill L, Wands JR. Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429 [Abstract] [Full Text] [Related]
8. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole. Elmer DB, Granai CO, Ball HG, Curry SL. Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320 [Abstract] [Full Text] [Related]
13. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)]. Tscherne G, Pürstner P. Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273 [Abstract] [Full Text] [Related]
14. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands. Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM. Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723 [Abstract] [Full Text] [Related]
15. Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy. Wolfberg AJ, Growdon WB, Feltmate CM, Goldstein DP, Genest DR, Chinchilla ME, Berkowitz RS, Lieberman ES. Obstet Gynecol; 2006 Aug; 108(2):393-6. PubMed ID: 16880311 [Abstract] [Full Text] [Related]
16. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases]. Zhang WY. Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204 [Abstract] [Full Text] [Related]
17. Detection of hCG in trophoblastic disease. The USA hCG reference service experience. Cole LA, Butler S. J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011 [Abstract] [Full Text] [Related]
18. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E. Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585 [Abstract] [Full Text] [Related]
19. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease]. Delpont PJ, Ruf H, Blanc B, Gamerre M, Adrai J, Conte M, Dupont S, Bellia-Rousseau J. Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299 [Abstract] [Full Text] [Related]
20. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma. Kohorn EI. Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394 [Abstract] [Full Text] [Related] Page: [Next] [New Search]